12 Health Care Stocks Moving In Monday's After-Market Session

Loading...
Loading...

Gainers

  • Nymox Pharmaceutical NYMX shares rose 21.8% to $0.5 during Monday's after-market session. The market value of their outstanding shares is at $45.2 million.
  • Brainstorm Cell BCLI stock rose 10.83% to $1.93. The company's market cap stands at $70.6 million.
  • OKYO Pharma OKYO stock moved upwards by 6.46% to $2.8. The company's market cap stands at $60.9 million.
  • Creative Medical Tech CELZ stock rose 6.28% to $0.57. The market value of their outstanding shares is at $8.0 million.
  • Athenex ATNX stock rose 5.44% to $0.19. The company's market cap stands at $29.8 million.
  • Virax Biolabs Group VRAX stock moved upwards by 5.28% to $0.78. The company's market cap stands at $9.9 million.

Losers

  • Xilio Therapeutics XLO stock fell 9.3% to $3.6 during Monday's after-market session. The market value of their outstanding shares is at $98.8 million.
  • Sonnet BioTherapeutics SONN shares declined by 8.2% to $1.12. The company's market cap stands at $8.8 million.
  • Integer Holdings ITGR shares fell 7.41% to $65.5. The company's market cap stands at $2.1 billion.
  • Heart Test Laboratories HSCS stock declined by 6.39% to $2.2. At the close, Heart Test Laboratories's trading volume reached 2.6 million shares. This is 6319.2% of its average volume over the last 100 days. The market value of their outstanding shares is at $18.3 million.
  • ASLAN Pharma ASLN shares declined by 5.77% to $0.64. The market value of their outstanding shares is at $44.6 million.
  • Calithera Biosciences CALA stock fell 5.66% to $0.42. The market value of their outstanding shares is at $2.0 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: MoversBZI-TFM
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...